Navigation Links
Preventing and improving treatment of Alzheimer's disease
Date:9/20/2013

This news release is available in French.

On September 19, INRS director general Daniel Coderre and INRSInstitut Armand-Frappier Centre director Charles M. Dozois announced the creation of the Louise and Andr Charron Research Chair in Alzheimer's Disease. Funded by a generous gift from the Louise and Andr Charron family to the Armand-Frappier Foundation of INRS University, the chair's research program will focus on prevention, early detection, and improved treatment of the disease, which is a growing problem in North America and around the world. Professor Charles Ramassamy of the INRSInstitut Armand-Frappier Centre is the first chairholder.

Over 35 million people worldwide have Alzheimer's disease, including more than 450,000 in Canada alone. Based on current data, if no action is taken, 65 million people around the world will have the disease by 2030, and that number will grow to 115 million by 2050. By the time Alzheimer's symptoms appear, 80% of the neurons involved in cognitive processing have degenerated and considerable damage has already been done. When the disease is diagnosed, the goal of treatment is to alleviate symptoms rather than to control the disease.

"In light of the alarming number of families affected by Alzheimer's disease, there is an urgent need to get to the root of this scourge. In our view, fundamental research holds the most promise for eradicating the disease," said Andr B. Charron, a member of the donor family.

Toward better patient care

For Professor Ramassamy, developing early detection tools for Alzheimer's disease is the first step in providing better patient care and improving patient quality of life. "We are looking for biomarkers that can not only show that neurodegeneration has begun in a patient, but also provide more insight into the stage of the disease. From there, clinical teams may be able to slow the progression of the disease or treat it, with the hope that patients will be able to maintain their independence for as long as possible."

What's more, current pharmacological treatments for Alzheimer's disease often have serious side effects that can interrupt treatment and negatively affect patient quality of life. The chair's research program will tackle this problem by identifying less toxic therapeutic moleculesmainly plant- and food-derived polyphenolsand harnessing nanoparticles to deliver them to the brain more efficiently, resulting in smaller doses.

"Under the direction of Professor Charles Ramassamy, this new research chair will not only develop innovative strategies for preventing and fighting Alzheimer's disease, it will also bring hope to current and future patients and their families. This generous gift from the Louise and Andr Charron family is a testament to our researchers' expertise and will help advance critical understanding of the disease in order to improve people's health and well-being," explained INRS director general Daniel Coderre.


'/>"/>

Contact: Stephanie Thibault
stephanie.thibault@adm.inrs.ca
450-687-5010 x8865
INRS
Source:Eurekalert

Related medicine news :

1. Berkeley, CA Periodontist Dr. Keith Chertok is Preventing Gum Disease during Pregnancy by Offering Laser Gum Surgery to Reduce Low Birth Weight Risks
2. Dr. Bonnie Weil Provides Tips on Preventing the Loneliness of the Empty Nest
3. Brandith Irwin, MD, Answers New Blog Question on Her Website SkinTour.com About Preventing Eye Wrinkles at Ages 30 to 40
4. Preventing Simple Surgical Mistakes That Can Have a Lasting Impact
5. Preventing eggs death from chemotherapy
6. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Uncomplicated New Diet Plans for Men to Aid in Preventing Certain Cancers Due to Excess Weight
7. Dr. Robin Fleck Shares Tips on Preventing Sunburn
8. Aspirin Equals Pricier Blood Thinner for Preventing Clots: Study
9. Likelihood of Spousal HPV Oral Infection, Predictors of Melanoma and Throat Cancer, Preventing Cancer Readmissions
10. Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
11. As Summer Approaches, Experts Offer Tips on Preventing Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Pigment Laser Tattoo Removal Center is proud ... the new PiQo4™ laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. ... picosecond laser on the market. Jeremy Miller, Tattoo Artist and former reality show ...
(Date:5/5/2016)... ... 2016 , ... Linfield College Online and Continuing Education is encouraging registered nurses ... application fee for all qualified applicants from May 1–14. Students need only go to ... applying . , With the RN to BSN degree program, all ...
(Date:5/5/2016)... ... ... Is the part in your hair widening? Are you finding more hairs ... good opportunity to raise awareness about a common condition among women: hair loss. , ... experience hair loss or ‘thinning’ by the time they reach menopause, but many remain ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Dr. Julie Lombardo, PT, DPT, MA, OCS, WCS, has been selected by the ... Practice Award. The WPTA Private Practice Award is awarded annually to a member ...
(Date:5/4/2016)... PA (PRWEB) , ... May 04, 2016 , ... Mother ... that grow – flowers, plants, fruits and vegetables. , Celebrate these women with ... your life, an unexpected gift with these five garden-themed options. , Vibrant, Edible, ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... Calif. , May 3, 2016  While you may be familiar with watching a film ... , also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned ... of innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... -- Pharmaceutical giant Johnson & Johnson has ... who says its talc-based powder products caused ovarian cancer. ... $5 million in compensatory damages and $50 million in ... ) , This is the second in ... the same court awarded $72 million to the family ...
(Date:5/3/2016)... JERUSALEM , May 3, 2016 ... (TASE: INTP), a clinical-stage biopharmaceutical company, today announced the ... Clinical and Regulatory Affairs. "Ms. Strauss-Levy has ... affairs, and has established an outstanding track record, having ... development and regulatory approval processes in the ...
Breaking Medicine Technology: